General Information of the Disease (ID: M6ADIS0182)
Name
Uveitis
ICD
ICD-11: 9A96
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Disease
In total 4 item(s) under this disease
Crosstalk ID: M6ACROT03204
m6A Regulator Methyltransferase-like 3 (METTL3)
m6A Target Histone-lysine N-methyltransferase ASH1L (ASH1L)
Epigenetic Regulator Histone-lysine N-methyltransferase ASH1L (ASH1L)
Regulated Target Histone H3 lysine 4 trimethylation (H3K4me3)
Crosstalk relationship m6A → Histone modification
Crosstalk ID: M6ACROT03205
m6A Regulator YTH domain-containing protein 2 (YTHDC2)
m6A Target Histone-lysine N-methyltransferase ASH1L (ASH1L)
Epigenetic Regulator Histone-lysine N-methyltransferase ASH1L (ASH1L)
Regulated Target Histone H3 lysine 4 trimethylation (H3K4me3)
Crosstalk relationship m6A → Histone modification
Crosstalk ID: M6ACROT05851
m6A Regulator Methyltransferase-like 3 (METTL3)
m6A Target Histone-lysine N-methyltransferase ASH1L (ASH1L)
Epigenetic Regulator Histone-lysine N-methyltransferase ASH1L (ASH1L)
Regulated Target Histone H3 lysine 4 trimethylation (H3K4me3)
Crosstalk relationship m6A → Histone modification
Crosstalk ID: M6ACROT05852
m6A Regulator YTH domain-containing protein 2 (YTHDC2)
m6A Target Histone-lysine N-methyltransferase ASH1L (ASH1L)
Epigenetic Regulator Histone-lysine N-methyltransferase ASH1L (ASH1L)
Regulated Target Histone H3 lysine 4 trimethylation (H3K4me3)
Crosstalk relationship m6A → Histone modification
References
Ref 1 Polyamines and the NMDA receptor: modifying intrinsic activities with aromatic substituents. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2837-41. doi: 10.1016/j.bmcl.2006.03.015. Epub 2006 Mar 24.
Ref 2 Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies. Ann Oncol. 2015 May;26(5):998-1005. doi: 10.1093/annonc/mdv026. Epub 2015 Jan 21.